Trials / Conditions / Basal Cell Carcinoma (BCC)

Basal Cell Carcinoma (BCC)

11 registered clinical trials studyying Basal Cell Carcinoma (BCC) — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Flash Radiotherapy for Skin Cancer NCT07455331	Jules Bordet Institute	Phase 2
Not Yet Recruiting	Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positiv NCT07361666	Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji	—
Recruiting	Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC NCT06981325	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Phase 2
Recruiting	Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas NCT06623201	Nathalie Zeitouni	Phase 1
Completed	Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma NCT07068568	Federico II University	—
Withdrawn	Intraoperative Margin Assessment During Mohs Surgery NCT02750033	Seton Healthcare Family	—
Completed	Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy NCT02144077	Biofrontera Bioscience GmbH	Phase 3
Unknown	Intralesional Cryosurgery for Basal Cell Carcinoma - a Feasibility Study NCT01633515	Carmel Medical Center	N/A
Completed	Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas NCT01108094	Stanford University	Phase 2
Completed	A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer NCT00670189	Bristol-Myers Squibb	Phase 1
Approved For Marketing	Expanded Access Use of Cemiplimab in Patients With Solid Tumors NCT06132191	Regeneron Pharmaceuticals	—